Get started

More results...

Filter by Content types

Alerts LATEST ALERTS

  • Morocco Campaign launched for awareness about risks associated with tobacco ...
  • Pakistan WHO pushes for tobacco tax increases ...
  • Vietnam Localities instructed to organise a response to World No Tobacco Day ...
  • Afghanistan - Bahrain - Egypt - Iran - Iraq - Jordan - Kuwait - Lebanon - Libya - Middle East - Morocco - Oman - Pakistan - Qatar - Saudi Arabia - Syria - Tunisia - United Arab Emirates - Yemen WHO regional director makes statement ahead of World No Tobacco Day ...
  • Lebanon Minister urges reform to combat tobacco ...
  • France Group of senators propose new nicotine pouch bill ...
  • United States Medical organisations express concern over HHS cuts ...
  • Nigeria Novel nicotine products become the centre of debate ...
  • Kuwait Health ministry uses social media to warn about tobacco advertising ...
  • Slovakia Civic associations call for restriction on nicotine product sales ...
  • Iraq Health ministry to lift ban on e-cigs and heated tobacco ...
  • Netherlands CBS releases 2024 smoking and vaping prevalence stats ...
News analysis

Healthy business? PMI completes its takeover of Vectura and Fertin Pharma

Written by || 16th September 2021 || News analysis | Major brands | GeographiesDenmark Europe United Kingdom

Philip Morris International (PMI) has concluded its controversial £1.1bn takeover of UK health firm Vectura, becoming its majority shareholder, along with that of the Danish oral-products manufacturer Fertin Pharma.

Confirming the completion of the deal today, Vectura, which develops and manufactures inhalers, said that the offer from the Big Tobacco company – £1.65 per share – now becomes “unconditional in all respects”, meaning the remaining stakeholders cannot prevent it.

Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

David Palacios Rubio

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.